103 related articles for article (PubMed ID: 20160371)
1. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
Shah MS; Jeevangi NK; Joshi A; Khattry N
J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Farina M; Scaini MC; Facchinetti A; Leoni A; Bernardi S; Catoni C; Morello E; Radici V; Frioni F; Campodonico E; Traverso G; Cavallaro G; Olivieri A; Galieni P; Renzo ND; Patriarca F; Carluccio P; Skert C; Maffini E; Pellizzeri S; Campisi G; Re F; Benedetti E; Rosato A; Almici C; Chiusolo P; Peccatori J; Malagola M; Poggiana C; Russo D
Transplant Cell Ther; 2024 Jun; 30(6):580.e1-580.e14. PubMed ID: 38582286
[TBL] [Abstract][Full Text] [Related]
3. Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide.
Jenner MJ; Micallef IN; Rohatiner AZ; Kelsey SM; Newland AC; Cavenagh JD
Med Oncol; 2000 Nov; 17(4):333-6. PubMed ID: 11114714
[TBL] [Abstract][Full Text] [Related]
4. Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study.
Ruutu T; Peczynski C; Houhou M; Polge E; Mohty M; Kröger N; Moiseev I; Penack O; Salooja N; Schoemans H; Duarte RF; Schroeder T; Passweg J; Wulf GG; Ganser A; Sica S; Arat M; Salmenniemi U; Broers AEC; Bourhis JH; Rambaldi A; Maertens J; Halaburda K; Zuckerman T; Labussière-Wallet H; Basak G; Koenecke C; Perić Z
Bone Marrow Transplant; 2023 Nov; 58(11):1209-1214. PubMed ID: 37573397
[TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease complicated with extreme hyperammonaemia (920 µmol/L) treated with defibrotide, lactulose, rifampin and haemodialysis.
Kabat M; Gill S; Kim K; Omidvari K; Lee R
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514165
[TBL] [Abstract][Full Text] [Related]
6. Veno occlusive disease: update on clinical management.
Senzolo M; Germani G; Cholongitas E; Burra P; Burroughs AK
World J Gastroenterol; 2007 Aug; 13(29):3918-24. PubMed ID: 17663504
[TBL] [Abstract][Full Text] [Related]
7. A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell-associated neurotoxicity syndrome.
Jacobson CA; Rosenthal AC; Arnason J; Agarwal S; Zhang P; Wu W; Amber V; Yared JA
Blood Adv; 2023 Nov; 7(21):6790-6799. PubMed ID: 37399456
[TBL] [Abstract][Full Text] [Related]
8. Veno-Occlusive Disease: A Life-Saving Novel Approach With Plasma Exchange, IVIG, and Steroid, Without Defibrotide.
Katlan B; Erkasar F; Topdemir M; Günaydin G; Ozen A
J Pediatr Hematol Oncol; 2024 May; ():. PubMed ID: 38810004
[TBL] [Abstract][Full Text] [Related]
9. Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome.
Laberko A; Aksenova M; Shipitsina I; Khamin I; Shcherbina A; Balashov D; Maschan A
Front Pediatr; 2020; 8():155. PubMed ID: 32432059
[No Abstract] [Full Text] [Related]
10. Constructing training set using distance between learnt graphical models of time series data on patient physiology, to predict disease scores.
Chakrabarty D; Wang K; Roy G; Bhojgaria A; Zhang C; Pavlu J; Chakrabartty J
PLoS One; 2023; 18(10):e0292404. PubMed ID: 37856497
[TBL] [Abstract][Full Text] [Related]
11. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Richardson PG; Riches ML; Kernan NA; Brochstein JA; Mineishi S; Termuhlen AM; Arai S; Grupp SA; Guinan EC; Martin PL; Steinbach G; Krishnan A; Nemecek ER; Giralt S; Rodriguez T; Duerst R; Doyle J; Antin JH; Smith A; Lehmann L; Champlin R; Gillio A; Bajwa R; D'Agostino RB; Massaro J; Warren D; Miloslavsky M; Hume RL; Iacobelli M; Nejadnik B; Hannah AL; Soiffer RJ
Blood; 2016 Mar; 127(13):1656-65. PubMed ID: 26825712
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
Nishida M; Sugita J; Iwai T; Sato M; Kudo Y; Omotehara S; Horie T; Sakano R; Hasegawa Y; Yasumoto A; Cho Y; Teshima T
Bone Marrow Transplant; 2022 Aug; 57(8):1338-1340. PubMed ID: 35614317
[No Abstract] [Full Text] [Related]
13. Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
Park JE; Choi YH; Cheon JE; Kim WS; Kim IO; Ryu YJ; Kim YJ; Hong CR; Kang HJ
Eur Radiol; 2018 Jun; 28(6):2291-2298. PubMed ID: 29294155
[TBL] [Abstract][Full Text] [Related]
14. High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.
Nunes AT; Jain P; Kleiner DE; Shah NN; Anandi P; Chinian F; Muranski P; Battiwalla M; Barrett AJ; Ito S
Bone Marrow Transplant; 2017 Jun; 52(6):926-928. PubMed ID: 28287645
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.
Richardson PG; Ho VT; Giralt S; Arai S; Mineishi S; Cutler C; Antin JH; Stavitzski N; Niederwieser D; Holler E; Carreras E; Soiffer R
Ther Adv Hematol; 2012 Aug; 3(4):253-65. PubMed ID: 23606935
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of late-onset veno-occlusive disease/sinusoidal obstruction syndrome after high dose intravenous busulfan and hematopoietic cell transplant.
Pai RK; van Besien K; Hart J; Artz AS; O'Donnell PH
Leuk Lymphoma; 2012 Aug; 53(8):1552-7. PubMed ID: 22280517
[TBL] [Abstract][Full Text] [Related]
17. Stem cells in clinical practice: applications and warnings.
Lodi D; Iannitti T; Palmieri B
J Exp Clin Cancer Res; 2011 Jan; 30(1):9. PubMed ID: 21241480
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
